IMR Press / EJGO / Volume 37 / Issue 1 / DOI: 10.12892/ejgo2783.2016

European Journal of Gynaecological Oncology (EJGO) is published by IMR Press from Volume 40 Issue 1 (2019). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on as a courtesy and upon agreement with S.O.G.

Original Research
The mandatory role of groin lymphadenectomy in clinical Stages IB and Ⅱ vulvar cancer
Show Less
1 First Clinic of Obstetrics and Gynecology, University of Medicine and Pharmacy, Targu-Mureş, Romania
2 Hippokratio General Hospital, Aristotle University, Thessaloniki, Greece
3 Second Clinic of Surgery, University of Medicine and Pharmacy Targu-Mureş, Romania
4 Department of Surgery, "Sf. Constantin" Hospital, Braşv, Romania
Eur. J. Gynaecol. Oncol. 2016, 37(1), 86–88;
Published: 10 February 2016

Purpose of investigation: To analyze the prevalence of inguinofemoral lymph nodes metastases in clinical Stages IB-Ⅱ vulva cancer. Materials and Methods: Twenty-two patients with FIGO Stages IB-Ⅱ FIGO vulva cancer with no clinically and imagistic evidence of nodes metastases were treated in the present clinic. The surgical procedures consisted in radical vulvectomy plus inguinofemoral lymphadenectomy. Results: The final pathological result was squamous carcinoma in 20 patients, vulva melanoma in one, and carcinosarcoma in one. The prevalence of positive lymph nodes was 45.4%. The median number of harvested lymph nodes was 14.0 per groin (between four and 27). Twelve patients (54.5%) developed some wound complications, but all were resolved. At the present time, 20 patients are alive, but the follow-up period is short for many of them; two patients died of disease. Conclusion: The prevalence of groin metastases in Stages IB-Ⅱ vulvar cancer is high. A thorough inguino-femoral dissection seems necessary, despite the high incidence of wound complications.
Vulvar cancer
Back to top